Dr. Tortella is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Broad and Vine Streets
Philadelphia, PA 19102Phone+1 215-762-2010Fax+1 215-762-4721
Education & Training
- Rutgers Health/New Jersey Medical SchoolFellowship, Surgical Critical Care, 1987 - 1988
- Beth Israel Deaconess Medical CenterResidency, Surgery, 1985 - 1986
- University of California (San Francisco)Fellowship, Surgical Critical Care, 1983 - 1985
- Beth Israel Deaconess Medical CenterResidency, Surgery, 1980 - 1983
- Harvard Medical SchoolClass of 1980
Certifications & Licensure
- CA State Medical License 1981 - Present
- PA State Medical License 1999 - 2024
- NJ State Medical License 1987 - 2023
- TX State Medical License 1980 - 1998
Awards, Honors, & Recognition
- Fellow (FCCM) American College of Critical Care Medicine
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Start of enrollment: 2005 Oct 01
- Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma Start of enrollment: 2006 May 01
Publications & Presentations
PubMed
- 44 citationsBetter adherence to prescribed treatment regimen is related to less chronic pain among adolescents and young adults with moderate or severe haemophilia.John M McLaughlin, Michelle Witkop, Angela Lambing, Terry L. Anderson, James Munn
Haemophilia. 2014-07-01 - 42 citationsRecombinant activated factor VII safety in trauma patients: results from the CONTROL trial.Richard P. Dutton, Michael Parr, Bartholomew J. Tortella, Howard R. Champion, Gordon R. Bernard
The Journal of Trauma. 2011-07-01 - 222 citationsResults of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.Carl J. Hauser, Kenneth D. Boffard, Richard P. Dutton, Gordon R. Bernard, Martin A. Croce
The Journal of Trauma. 2010-09-01
Press Mentions
- A New Era for Genetic MedicineOctober 9th, 2018
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: